AstraZeneca Puts $270 Million Cambridge Expansion On Hold Amid Shifting U.K. Business Climate
AstraZeneca Unveils $50 Billion U.S. Manufacturing Push in Bid to Expand Market Share and Counter Tariff Threats
FDA Approves Merck’s RSV Shot for Infants, Intensifying Competition with Sanofi and AstraZeneca
Pump Radar
Stock Alerts